Journal Home
Search for

Volume 9, Issue 1, Pages 36-41 (January 2010)


View previous. 10 of 20 View next.

Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer

Ken Yoshida1Corresponding Author Informationemail address, Hideya Yamazaki2, Takayuki Nose3, Hiroya Shiomi4, Mineo Yoshida1, Mari Mikami1, Tadashi Takenaka1, Tadayuki Kotsuma1, Eiichi Tanaka1, Keiko Kuriyama1, Yasunori Harada5, Akira Tohda5, Yutaka Yasunaga5, Toshitsugu Oka5

Received 31 December 2008; received in revised form 31 March 2009; accepted 3 April 2009. published online 07 September 2009.

Abstract 

Purpose

To introduce an effective ambulatory technique in high-dose-rate interstitial brachytherapy (HDR-ISBT) for prostate cancer, we investigated the displacement distance using our novel calculation method.

Methods and Materials

Sixty-four patients treated with HDR-ISBT as monotherapy were examined. Of these, 4, 17, and 43 patients were administered treatment doses of 38Gy (3 days), 49Gy (4 days), and 54Gy (5 days), respectively. For dose administration, we used 776 flexible applicators with a removable template (ambulatory technique).

Using CT images, we calculated the relative coordinates of the metal markers and applicators. From these coordinates, to analyze displacement during treatment, we measured the distance between the tip of the needle applicator and the center of gravity of the markers along the average applicator vector.

Results

The median displacement distance for all applicators was 7mm (range, −14 to 24), and that of each treatment schedule was 4, 6, and 9mm for 38, 49, and 54Gy, respectively. Of the 776 applicators, displacement of >10mm was seen in 198 (26%) applicators and >15mm in 57 (7%) applicators.

Body height (p<0.0001) and anticoagulant usage (p<0.0001) were significant factors influencing displacement.

Conclusions

We investigated needle applicator displacement using our unique method. Additional cranial margins are necessary if there is no repositioning of the dwell position. CT scanning should be performed daily during treatment for checking the position of the applicator to detect and rectify the issue of displacement.

1 Department of Radiology, National Hospital Organization Osaka National Hospital, Osaka City, Japan

2 Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan

3 Department of Radiation Oncology, Cancer Institute Hospital, Tokyo, Japan

4 Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan

5 Department of Urology, National Hospital Organization Osaka National Hospital, Osaka City, Japan

Corresponding Author InformationCorresponding author. Department of Radiology, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka 540-0006, Japan. Tel.: +81-6-6942-1331; fax: +81-6-6943-6467.

 Conflict of interest: none.

PII: S1538-4721(09)00269-4

doi:10.1016/j.brachy.2009.04.006


View previous. 10 of 20 View next.